Target- |
MechanismStem cell replacements |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Safety and Feasibility of Autologous Induced Pluripotent Stem Cells of Cardiac Lineage in Subjects With Congenital Heart Disease
The goal of this clinical trial is to test the safety of lab-grown heart cells made from stem cells in subjects with congenital heart disease. The main questions it aims to answer are:
Is this product safe to deliver to humans
Is the conduct of this trial feasible
Participants will be asked to:
Agree to testing and monitoring before and after product administration
Receive investigational product
Agree to lifelong follow-up Researchers will compare subjects from the same pool to see if there is a difference between treated and untreated subjects.
100 Clinical Results associated with HeartWorks
0 Patents (Medical) associated with HeartWorks
100 Deals associated with HeartWorks
100 Translational Medicine associated with HeartWorks